European Case Law Identifier: | ECLI:EP:BA:2015:T030111.20150203 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 03 February 2015 | ||||||||
Case number: | T 0301/11 | ||||||||
Application number: | 02735680.7 | ||||||||
IPC class: | A61K 9/48 A61K 9/50 A61K 9/14 A61K 9/16 |
||||||||
Language of proceedings: | EN | ||||||||
Distribution: | D | ||||||||
Download and more information: |
|
||||||||
Title of application: | METHOD OF ENCAPSULATING AN ACTIVE SUBSTANCE | ||||||||
Applicant name: | CSIR | ||||||||
Opponent name: | Critical Pharmaceuticals Limited | ||||||||
Board: | 3.3.07 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Amendments - added subject-matter (yes) Requests filed with the statement of grounds - admitted (no) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t110301eu1.html
Date retrieved: 17 May 2021